Pages that link to "Q77602017"
Jump to navigation
Jump to search
The following pages link to Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation (Q77602017):
Displaying 13 items.
- Adoptive T cell therapy for cancer in the clinic (Q24680405) (← links)
- Chimeric antigen receptor therapy for cancer (Q27013599) (← links)
- Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination (Q28068378) (← links)
- Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction (Q33384384) (← links)
- Chemoimmunotherapy (Q34058792) (← links)
- Chemotherapy and tumor immunity: an unexpected collaboration (Q34909777) (← links)
- Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors (Q36304574) (← links)
- Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. (Q37100759) (← links)
- Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect. (Q37201903) (← links)
- Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation (Q37354189) (← links)
- Tuning cancer fate: the unremitting role of host immunity. (Q39239026) (← links)
- Treatment with GM-CSF Secreting Myeloid Leukemia Cell Vaccine Prior to Autologous-BMT Improves the Survival of Leukemia-Challenged Mice (Q39644103) (← links)
- Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12. (Q52691583) (← links)